A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study.

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Sep; 118(3):303-7.

View in: PubMed

subject areas

Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carboplatin
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Administration Schedule
Fallopian Tube Neoplasms
Fallopian Tube Neoplasms
Female
Female
Filgrastim
Filgrastim
Granulocyte Colony-Stimulating Factor
Granulocyte Colony-Stimulating Factor
Hematologic Diseases
Hematologic Diseases
Humans
Humans
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Peripheral Nervous System Diseases
Peripheral Nervous System Diseases
Peritoneal Neoplasms
Peritoneal Neoplasms
Polyethylene Glycols
Polyethylene Glycols
Recombinant Proteins
Recombinant Proteins

authors with profiles

Robert S Mannel